Drug intelligence / Profile preview

Kangfu Tincture

Development stage: Unknown
Lead developer: 安徽安科余良卿药业
Modality: Small Molecules
Administration: Topical

Overview

Kangfu Tincture (康肤酊) is a topical Traditional Chinese Medicine (TCM) formulation developed and manufactured by Anhui Anke Yuliangqing Pharmaceutical. It is primarily indicated for the treatment of eczema, neurodermatitis, and skin pruritus. The tincture is composed of various herbal extracts known in TCM for their properties in clearing heat, drying dampness, and relieving itching. As a TCM product, its therapeutic effects are attributed to the synergistic action of its botanical components rather than a single molecular target. It is approved in China for dermatological use and is part of the product portfolio of Anhui Anke Yuliangqing Pharmaceutical, a subsidiary of Anhui Anke Biotechnology.

Brand names: Kangfu Tincture康肤酊
Other names: 康肤酊

Beyond the preview

Go deeper on Kangfu Tincture.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kangfu Tincture.

Explore the full profile